Product NDC: | 0074-4380 |
Proprietary Name: | Nimbex |
Non Proprietary Name: | Cisatracurium besylate |
Active Ingredient(s): | 2 mg/mL & nbsp; Cisatracurium besylate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-4380 |
Labeler Name: | Abbott Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020551 |
Marketing Category: | NDA |
Start Marketing Date: | 20101209 |
Package NDC: | 0074-4380-10 |
Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (0074-4380-10) |
NDC Code | 0074-4380-10 |
Proprietary Name | Nimbex |
Package Description | 10 mL in 1 VIAL, MULTI-DOSE (0074-4380-10) |
Product NDC | 0074-4380 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cisatracurium besylate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101209 |
Marketing Category Name | NDA |
Labeler Name | Abbott Laboratories |
Substance Name | CISATRACURIUM BESYLATE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |